Quantitative targets for revenue, operating profit, ROS, etc. in the 2023 Medium-Term Management Plan
First written in FY2022-Q1. 1 of 6 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.
- FY2024DroppedAnnual report
「Against this backdrop, the Group formulated a new three-year plan, the 2026 Medium-Term Management Plan, and announced it on 28 March this year.」
The 2023 Medium-Term Management Plan has ended and the Company has transitioned to the new 2026 Medium-Term Management Plan. The current plan no longer contains a statement carrying forward the expectation that the 2023 plan's earnings targets would be missed. - FY2023The second-year targets of the 2023 Medium-Term Management Plan were missed, and the plan as a whole is expected to fall short.Annual report
「For FY2022, the second year of the 2023 Medium-Term Management Plan, actual sales were ¥21.6 billion versus a plan of ¥22.0 billion, operating profit was ¥900 million versus a plan of ¥2.4 billion, and ROS (operating margin) was 4% versus a plan of 11%.」
Sales, operating profit and ROS all fell short of plan in the second year. The Company also stated that the three-year targets of ¥68.0 billion in sales, ¥7.3 billion in operating profit and ROS of at least 10% are expected to be missed. - FY2022The quantitative targets for the first year of the 2023 Medium-Term Management Plan were missed.Annual report
「Actual results for FY2021, the first year of the 2023 medium-term management plan, were net sales of ¥22.3 billion versus the ¥23 billion target, operating profit of ¥1.6 billion versus the ¥2.2 billion target, and ROS (operating margin) of 7% versus the 10% target.」
First-year actual results were below plan for sales, operating profit and ROS. However, the overall three-year targets of ¥68.0 billion in sales, ¥7.3 billion in operating profit and ROS of at least 10% remain unchanged. - FY2022-Q3RestatedAnnual report
「FY2021 (*) (including April 2021-March 2022) / FY2022 / FY2023: Sales ¥23,000 million / ¥21,500 million / ¥22,000 million / ¥23,000 million; operating profit ¥2,200 million / ¥1,800 million / ¥2,400 million / ¥2,700 million; net income ¥1,350 million / ¥1,050 million / ¥1,700 million / ¥1,900 million; operating margin 10% / 8% / 11% / 12%.」
The annual quantitative targets for sales, operating profit, net income, ROS and other metrics under the 2023 Medium-Term Management Plan were reproduced unchanged. - FY2022-Q2Details of the 15-month FY2021 financial resultsAnnual report
「FY2021 (*) (including April 2021-March 2022) / FY2022 / FY2023: Sales ¥23,000 million / ¥21,500 million / ¥22,000 million / ¥23,000 million; operating profit ¥2,200 million / ¥1,800 million / ¥2,400 million / ¥2,700 million; net income ¥1,350 million / ¥1,050 million / ¥1,700 million / ¥1,900 million; operating margin 10% / 8% / 11% / 12%.」
For the 2023 Medium-Term Management Plan, in addition to the full-year FY2021 plan figures based on 15-month financial results for overseas consolidated subsidiaries, figures for the 12 months from April 2021 through March 2022 were also presented: sales of ¥21,500 million, operating profit of ¥1,800 million, net income of ¥1,050 million and ROS of 8%. - FY2022-Q1First statedAnnual report
「On 23 June 2021, the Group formulated and announced a new medium-term management plan covering the three-year period from FY2021 through FY2023. FY2021 (*) / FY2022 / FY2023: Sales ¥23,000 million / ¥22,000 million / ¥23,000 million; operating profit ¥2,200 million / ¥2,400 million / ¥2,700 million; net income ¥1,350 million / ¥1,700 million / ¥1,900 million; operating margin 10% / 11% / 12%.」
The new medium-term management plan for FY2021 through FY2023 presented annual quantitative targets for sales, operating profit, net income and operating margin for the first time. Targets for capital expenditure and the consolidated dividend payout ratio were also included.